These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35638851)

  • 41. Discovery of novel cell-penetrating and tumor-targeting peptide-drug conjugate (PDC) for programmable delivery of paclitaxel and cancer treatment.
    Deng X; Mai R; Zhang C; Yu D; Ren Y; Li G; Cheng B; Li L; Yu Z; Chen J
    Eur J Med Chem; 2021 Mar; 213():113050. PubMed ID: 33280896
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The programmed site-specific delivery of the angiostatin sunitinib and chemotherapeutic paclitaxel for highly efficient tumor treatment.
    He J; Xiao H; Li B; Peng Y; Li X; Wang Y; Adamus G; Kowalczuk M; Shuai X
    J Mater Chem B; 2019 Aug; 7(32):4953-4962. PubMed ID: 31411627
    [TBL] [Abstract][Full Text] [Related]  

  • 43.
    Pei P; Chen L; Guan X; Wei P; Kang X; Gong L; Liu L; Guo W; Gu R; Wang L; Zhao C; Liang JF; Luo SZ
    ACS Appl Mater Interfaces; 2024 Sep; 16(37):49013-49029. PubMed ID: 39231128
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HPMA copolymer conjugates of paclitaxel and docetaxel with pH-controlled drug release.
    Etrych T; Sírová M; Starovoytova L; Ríhová B; Ulbrich K
    Mol Pharm; 2010 Aug; 7(4):1015-26. PubMed ID: 20518512
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A smart polymeric platform for multistage nucleus-targeted anticancer drug delivery.
    Zhong J; Li L; Zhu X; Guan S; Yang Q; Zhou Z; Zhang Z; Huang Y
    Biomaterials; 2015 Oct; 65():43-55. PubMed ID: 26142775
    [TBL] [Abstract][Full Text] [Related]  

  • 46. pH and redox dual responsive carrier-free anticancer drug nanoparticles for targeted delivery and synergistic therapy.
    Zhou M; Wei W; Chen X; Xu X; Zhang X; Zhang X
    Nanomedicine; 2019 Aug; 20():102008. PubMed ID: 31121311
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multistage pH-responsive codelivery liposomal platform for synergistic cancer therapy.
    Zhao T; Liang C; Zhao Y; Xue X; Ma Z; Qi J; Shen H; Yang S; Zhang J; Jia Q; Du Q; Cao D; Xiang B; Zhang H; Qi X
    J Nanobiotechnology; 2022 Apr; 20(1):177. PubMed ID: 35366888
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A pH-responsive α-helical cell penetrating peptide-mediated liposomal delivery system.
    Zhang Q; Tang J; Fu L; Ran R; Liu Y; Yuan M; He Q
    Biomaterials; 2013 Oct; 34(32):7980-93. PubMed ID: 23891517
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Smart nanoplatform for sequential drug release and enhanced chemo-thermal effect of dual drug loaded gold nanorod vesicles for cancer therapy.
    Zhu F; Tan G; Zhong Y; Jiang Y; Cai L; Yu Z; Liu S; Ren F
    J Nanobiotechnology; 2019 Mar; 17(1):44. PubMed ID: 30917812
    [TBL] [Abstract][Full Text] [Related]  

  • 50. RGD peptide-decorated micelles assembled from polymer-paclitaxel conjugates towards gastric cancer therapy.
    Shi J; Liu S; Yu Y; He C; Tan L; Shen YM
    Colloids Surf B Biointerfaces; 2019 Aug; 180():58-67. PubMed ID: 31028965
    [TBL] [Abstract][Full Text] [Related]  

  • 51. pH-responsive stearic acid-O-carboxymethyl chitosan assemblies as carriers delivering small molecular drug for chemotherapy.
    Luo F; Fan Z; Yin W; Yang L; Li T; Zhong L; Li Y; Wang S; Yan J; Hou Z; Zhang Q
    Mater Sci Eng C Mater Biol Appl; 2019 Dec; 105():110107. PubMed ID: 31546448
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Programmed pH/reduction-responsive nanoparticles for efficient delivery of antitumor agents in vivo.
    Chen WL; Yang SD; Li F; Qu CX; Liu Y; Wang Y; Wang DD; Zhang XN
    Acta Biomater; 2018 Nov; 81():219-230. PubMed ID: 30267887
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dual-responsive polymersomes as anticancer drug carriers for the co-delivery of doxorubicin and paclitaxel.
    Zhou D; Fei Z; Jin L; Zhou P; Li C; Liu X; Zhao C
    J Mater Chem B; 2021 Jan; 9(3):801-808. PubMed ID: 33336680
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bacterial microbots for acid-labile release of hybrid micelles to promote the synergistic antitumor efficacy.
    Xie S; Chen M; Song X; Zhang Z; Zhang Z; Chen Z; Li X
    Acta Biomater; 2018 Sep; 78():198-210. PubMed ID: 30036720
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel brain-targeted nanomicelles for anti-glioma therapy mediated by the ApoE-enriched protein corona in vivo.
    Zhang ZA; Xin X; Liu C; Liu YH; Duan HX; Qi LL; Zhang YY; Zhao HM; Chen LQ; Jin MJ; Gao ZG; Huang W
    J Nanobiotechnology; 2021 Dec; 19(1):453. PubMed ID: 34963449
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phosphatidylserine targeting peptide-functionalized pH sensitive mixed micelles for enhanced anti-tumor drug delivery.
    Guan S; Zhang Q; Bao J; Duan T; Hu R; Czech T; Tang J
    Eur J Pharm Biopharm; 2020 Feb; 147():87-101. PubMed ID: 31899369
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Injectable and pH-responsive self-assembled peptide hydrogel for promoted tumor cell uptake and enhanced cancer chemotherapy.
    Zhang J; Lin W; Yang L; Zhang A; Zhang Y; Liu J; Liu J
    Biomater Sci; 2022 Feb; 10(3):854-862. PubMed ID: 35006223
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PEGylation of paclitaxel largely improves its safety and anti-tumor efficacy following pulmonary delivery in a mouse model of lung carcinoma.
    Luo T; Loira-Pastoriza C; Patil HP; Ucakar B; Muccioli GG; Bosquillon C; Vanbever R
    J Control Release; 2016 Oct; 239():62-71. PubMed ID: 27515664
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A sequentially responsive and structure-transformable nanoparticle with a comprehensively improved 'CAPIR cascade' for enhanced antitumor effect.
    Xu C; Sun Y; Yu Y; Hu M; Yang C; Zhang Z
    Nanoscale; 2019 Jan; 11(3):1177-1194. PubMed ID: 30601512
    [TBL] [Abstract][Full Text] [Related]  

  • 60. α-Amylase- and Redox-Responsive Nanoparticles for Tumor-Targeted Drug Delivery.
    Li Y; Hu H; Zhou Q; Ao Y; Xiao C; Wan J; Wan Y; Xu H; Li Z; Yang X
    ACS Appl Mater Interfaces; 2017 Jun; 9(22):19215-19230. PubMed ID: 28513132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.